FDA Drug recall D-0996-2019
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154…
- FDA Drug
- Class III
- terminated
- Published 2019-03-20
On 2019-03-20 the FDA classified a Class III recall of Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154… by Lannett, citing failed Dissolution Specifications.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0996-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-02-21 |
| Published | 2019-03-20 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Lannett |
| Distribution | US |
Product
Oxybutynin Chloride, Extended-Release Tablets USP, 10 mg, 100 Tablet, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19154 NDC: 62175-271-37
Reason
Failed Dissolution Specifications
Identifiers
| ndc | 62175-270-37 |
|---|---|
| ndc | 62175-270-41 |
| ndc | 62175-271-37 |
| ndc | 62175-271-41 |
| ndc | 62175-272-37 |
| ndc | 62175-272-41 |
| code_info | Lots: 18226783A, exp 07/2021 and 18232540A, exp 08/2021 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0996-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.